1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR4 Inhibitors

CXCR4 Inhibitors

CXCR

CXCR1

CXCR2

CXCR3

CXCR4

CXCR7

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform CXCR4 together.

Please try each isoform separately.

CXCR4 Specific Inhibitors, Agonists, Antagonists & Modulators
Product Name CXCR4 CXCR7 CXCR4 Selectivity Purity
Plerixafor
125I-CXCL12-CXCR4, IC50: 44 nM
  Selective Antagonist >98.0%
NUCC-390 dihydrochloride
CXCR4
  Selective Agonist 99.59%
Plerixafor octahydrochloride
125I-CXCL12-CXCR4, IC50: 44 nM
  Selective Antagonist >98.0%
Mavorixafor trihydrochloride
125I-SDF-CXCR4, IC50: 13 nM
  Selective Antagonist 99.14%
Motixafortide
CXCR4, IC50: ~1 nM
  Selective Antagonist 98.27%
LY2510924
125I-SDF-1α-CXCR4, IC50: 79.7 pM
125I-SDF-1α-CXCR4, Ki: 49.5 pM
  Selective Inhibitor 99.91%
IT1t dihydrochloride
CXCL12/CXCR4, IC50: 2.1 nM
  Selective Antagonist 99.97%
Burixafor hydrobromide
CXCR4
  Selective Antagonist >98.0%
MSX-122
CXCR4/CXCL12, IC50: ~10 nM
  Selective Antagonist 98.29%
USL311
CXCR4
  Selective Antagonist 99.97%
AMD 3465 hexahydrobromide
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
  Selective Antagonist 98.79%
WZ811
CXCR4, EC50: 0.3 nM
  Selective Antagonist >99.0%
FC131 TFA
125I-SDF-1-CXCR4, IC50: 4.5 nM
  Selective Antagonist 99.87%
Balixafortide TFA
CXCR4, IC50: <10 nM
  Selective Antagonist 98.19%
ALX 40-4C Trifluoroacetate
SDF-1-CXCR4, Ki: 1 μM
  Selective Inhibitor 98.15%
ALX 40-4C
SDF-1-CXCR4, Ki: 1 μM
  Selective Inhibitor
NUCC-390
CXCR4
  Selective Agonist
Mavorixafor
125I-SDF-CXCR4, IC50: 13 nM
  Selective Antagonist
AMD 3465
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
  Selective Antagonist
MSX-127
CXCR4
  Selective Antagonist
CTCE-9908 TFA
CXCR4
  Selective Antagonist
TC14012 TFA
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
Selective Modulator
MSX-130
CXCR4
  Selective Antagonist
Baohuoside I
CXCR4
  Pan Inhibitor 99.70%